SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-041947
Filing Date
2020-04-01
Accepted
2020-04-01 17:19:37
Documents
5
Effectiveness Date
2020-04-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm202094d3_defa14a.htm DEFA14A 20517
2 GRAPHIC tm202094d3_defaimg001.jpg GRAPHIC 121800
3 GRAPHIC tm202094d3_defaimg002.jpg GRAPHIC 189546
4 GRAPHIC tm202094d3_defaimg003.jpg GRAPHIC 75675
5 GRAPHIC tm202094d3_defaimg004.jpg GRAPHIC 6866
  Complete submission text file 0001104659-20-041947.txt   560175
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-29889 | Film No.: 20766409
SIC: 2834 Pharmaceutical Preparations